Eisenberg, D., David, R. B., Ettner, S. L., Appel, S., Wilkey, S., Van Rompey, M., et al. (1998). Trends in alternative medicine use in the United States; 1990-1997. Journal of the American Medical Association, 280, 1569-1575.
2.
Ernst, E. (1999). Funding research into complementary medicine: The situation in Britain. Complementary Therapies in Medicine, 7, 250-253.
3.
Ernst, E., Resch, K. L., & Uher, E. M. (1992). Reviewer bias. Annals of Internal Medicine, 116, 958.
4.
Hrobjartsson, A., & Brorson, S. (2002). Interpreting results from randomized clinical trials of complementary/alternative interventions: The role of trial quality and pre-trial beliefs. In D. Callahan (Ed.), The role of complementary and alternative medicine (pp. 107-121). Washington, DC: Georgetown University Press.
5.
International Committee of Medical Journal Editors. (2001). Uniform requirements for manuscripts submitted to biomedical journals. Retrieved December 17, 2002, from www.icmje.org.
6.
Nicolai, G., Friede, P., Werner, M., & Zanker, K. S. (1997). Donor-dependent and dose-dependent variation in the induction of T-lymphocyte locomotion in a three-dimensional collagen matrix system by a mistletoe preparation (Iscador). Anticancer Drugs, 8(suppl. 1), S61-S64.
7.
The science of alternative medicine [issue]. (2002, December 2). Newsweek.
8.
Vickers, A., Goyal, N., Harland, R., & Rees, R. (1998). Do certain countries produce only positive results—A systematic review of controlled trials. Controlled Clinical Trials, 19, 159-166.
